LRRK2 and supranuclear palsy, progressive, 1: The presence of an A-allele in the LRRK2 genotype (rs2242367) was associated with a shorter disease duration at enrolment in the PSP group (3.5 ± 2.0 years versus 5.1 ± 3.4 years, P = 0.02).